Proctitis after brachytherapy for rectal cancer: clinical and dosimetric factors - The HERBERT study

被引：0
|
作者：
Rijkmans, E. C. [1 ]
Nout, R. A. [1 ]
Kerkhof, E. M. [1 ]
Cats, A. [2 ]
Van Triest, B. [3 ]
Inderson, A. [4 ]
Van den Ende, R. P. J. [1 ]
Laman, M. S. [1 ]
Ketelaars, M. [1 ]
Marijnen, C. A. M. [1 ]
机构：
[1] LUMC, Dept Radiotherapy, Leiden, Netherlands
[2] Netherlands Canc Inst, Dept Gastroenterol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[4] LUMC, Dept Gastroenterol, Leiden, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)30590-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0280
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [1] Factors associated with complete response after brachytherapy for rectal cancer; the HERBERT study.
    Rijkmans, E. C.
    Nout, R. A.
    Kerkhof, E. M.
    Cats, A.
    Van Triest, B.
    Inderson, A.
    Van den Ende, R. P. J.
    Laman, M. S.
    Ketelaars, M.
    Marijnen, C. A. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S172 - S173
  • [2] Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study
    Rijkmans, Eva C.
    Marijnen, Corrie A. M.
    van Triest, Baukelien
    Ketelaars, Martijn
    Cats, Annemieke
    Inderson, Akin
    van den Ende, Roy P. J.
    Laman, Mirjam S.
    Kerkhof, Ellen M.
    Nout, Remi A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 176 - 182
  • [3] Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study
    Rijkmans, E. C.
    van Triest, B.
    Nout, R. A.
    Kerkhof, E. M.
    Buijsen, J.
    Rozema, T.
    Franssen, J. H.
    Velema, L. A.
    Laman, M. S.
    Cats, A.
    Marijnen, C. A. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 126 (03) : 417 - 423
  • [4] Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with 131Cs brachytherapy for prostate cancer
    Gokhale, Abhay S.
    Beriwal, Sushil
    Smith, Ryan P.
    Li, Xiang
    Benoit, Ronald
    [J]. BRACHYTHERAPY, 2010, 9 (04) : 328 - 334
  • [5] Dosimetric correlation of rectal dose and rectal distension in cervical cancer patients undergoing brachytherapy
    Bashir, I.
    Chufal, K.
    Thakwani, A.
    Bhatnagar, A.
    Jain, S.
    Khullar, P.
    Ghosh, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S371 - S372
  • [6] Rectal toxicity with MUPIT Interstitial Brachytherapy - Predictors, clinical and dosimetric outcomes
    Pareek, V.
    Bhalavat, R.
    Chandra, M.
    Bakshi, C.
    Bhambhani, N.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1177 - S1178
  • [7] Dosimetric parameters of rectal toxicity and fistula formation after prostate brachytherapy
    Mayadev, J. S.
    Merrick, G.
    Wallner, K.
    Arthurs-Cutshall, S.
    Bittner, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S313 - S313
  • [8] Dosimetric comparison of rectal dose reduction methods in brachytherapy for cervical cancer
    Sawada, M.
    Shiraishi, Y.
    Nemoto, T.
    Tanaka, T.
    Kota, R.
    Koike, N.
    Shigematsu, N.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1601 - S1602
  • [9] Effect of Lowering of the Rectal Probe in interstitial HDR Brachytherapy for Prostate Cancer as a Boost to the Frequency of Proctitis
    Schuetze, A.
    Schneider, D.
    Baumgart, O.
    Fueller, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 114 - 114
  • [10] Clinical and Dosimetric parameters for Late Rectal toxicities after radical IMRT for prostate cancer
    Ng, Y. H. B.
    Yu, L. M.
    Lau, T. S.
    Law, K. S.
    Cheng, C. K. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S73 - S74
12345